BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27932180)

  • 1. Liver Transplant Recipient With Tumefactive Demyelinating Lesions: A Case Report and Literature Review.
    Wan DL; Ren KW; Zhang LL; Wang B; Zhai ZL; Zhang XY; Yang YC; Zheng SS
    Transplant Proc; 2016 Nov; 48(9):3197-3202. PubMed ID: 27932180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Transplant Recipient With Tumefactive Demyelinating Lesions: A Case Report and Literature Review.
    Mu L; Wang M; Cheng L; Liu P; Wang K
    Transplant Proc; 2023 Oct; 55(8):1906-1909. PubMed ID: 37541863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
    Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
    J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumefactive demyelinating lesions: A comprehensive review.
    Algahtani H; Shirah B; Alassiri A
    Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
    Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
    J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of pediatric multiple sclerosis presenting with a tumefactive demyelinating lesion].
    Majima H; Ito T; Koyama N
    Rinsho Shinkeigaku; 2017 Feb; 57(2):88-91. PubMed ID: 28132974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central pontine myelinolysis with widespread extrapontine lesions: a report of two cases.
    Kalnins RM; Berkovic SF; Bladin PF
    Clin Exp Neurol; 1984; 20():189-202. PubMed ID: 6568941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central pontine and extrapontine myelinolysis: a report of 58 cases.
    Gocht A; Colmant HJ
    Clin Neuropathol; 1987; 6(6):262-70. PubMed ID: 3322623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report of central pontine and extrapontine myelinolysis which occurred during pregnancy and was accompanied by choreic movement].
    Tsutada T; Hayashi H; Kitano S; Imai T; Nishimura S
    Rinsho Shinkeigaku; 1989 Oct; 29(10):1294-7. PubMed ID: 2605837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumefactive Demyelinating Lesions and Pregnancy.
    Plantone D; Piantadosi C; Ruggieri S; Anelli V; Koudriavtseva T
    Neurol India; 2019; 67(6):1519-1521. PubMed ID: 31857550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central pontine myelinolysis after orthotopic liver transplant-a rare complication.
    Al-Sarraf AJ; Haque M; Pudek M; Yoshida EM
    Exp Clin Transplant; 2010 Dec; 8(4):321-4. PubMed ID: 21143100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of extrapontine myelinolysis preceding central pontine myelinolysis].
    Armand JP; Dousset V; Winnock S; Viaud B; Berge J; Caillé JM
    J Radiol; 1995 Aug; 76(8):521-3. PubMed ID: 7473392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumefactive Demyelination Appearing as Multiple Cystic Brain Lesions.
    Wynne D; Hung Ho BK; Han TF
    World Neurosurg; 2021 Sep; 153():6-8. PubMed ID: 34129977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumefactive demyelinating lesions (TDLs): A case series of clinicoradiological features.
    Jain RS; Khan I; Kandelwal K; Desai T
    Clin Neurol Neurosurg; 2017 Nov; 162():91-94. PubMed ID: 28987645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmotic demyelination syndromes: central and extrapontine myelinolysis.
    Huq S; Wong M; Chan H; Crimmins D
    J Clin Neurosci; 2007 Jul; 14(7):684-8. PubMed ID: 17462902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmotic stress, osmotic myelinolysis, and oligodendrocyte topography.
    Riggs JE; Schochet SS
    Arch Pathol Lab Med; 1989 Dec; 113(12):1386-8. PubMed ID: 2589951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapontine Myelinolysis and Reversible Parkinsonism After Hyponatremia Correction in a Case of Pituitary Adenoma: Hypopituitarism as a Predisposition for Osmotic Demyelination.
    Perikal PJ; Jagannatha AT; Khanapure KS; Furtado SV; Joshi KC; Hegde AS
    World Neurosurg; 2018 Oct; 118():304-310. PubMed ID: 30055367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumefactive demyelinating lesion: experience with two unusual patients.
    Sinha MK; Garg RK; Bhatt ML; Chandra A
    J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.